|
Transcriptome-based response predictor to identify potential responders among patients with negative standard markers for response to immune checkpoint blockers. |
|
|
Employment - Pangaea Biotech |
Stock and Other Ownership Interests - Pangaea Biotech |
|
|
Employment - Pangaea Biotech |
Stock and Other Ownership Interests - Pangaea Biotech |
|
|
Employment - Pangaea Biotech |
Stock and Other Ownership Interests - Pangaea Biotech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - MedAware; Metabomed |
Consulting or Advisory Role - Pangaea Biotech |
Patents, Royalties, Other Intellectual Property - Tel-Aviv University, U Maryland and NCI |
(OPTIONAL) Uncompensated Relationships - Pangaea Biotech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Pangaea Biotech |
Leadership - Pangaea Biotech |
Stock and Other Ownership Interests - MedAware; Pangaea Biotech |
Patents, Royalties, Other Intellectual Property - Pangaea Biotech |
|
|
No Relationships to Disclose |